Scilex Holding Co. (SCLX)
5.495
+0.06
(+1.20%)
USD |
NASDAQ |
Aug 31, 16:00
5.59
+0.10
(+1.73%)
Pre-Market: 09:13
Scilex Net Income (Quarterly) : -116.22M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -116.22M |
| March 31, 2026 | -45.65M |
| December 31, 2025 | -46.10M |
| September 30, 2025 | -257.82M |
| June 30, 2025 | -87.80M |
| March 31, 2025 | -26.08M |
| December 31, 2024 | -6.46M |
| September 30, 2024 | -4.388M |
| June 30, 2024 | -37.58M |
| March 31, 2024 | -24.38M |
| December 31, 2023 | -21.40M |
| September 30, 2023 | -35.53M |
| Date | Value |
|---|---|
| June 30, 2023 | -26.65M |
| March 31, 2023 | -30.75M |
| December 31, 2022 | -23.99M |
| September 30, 2022 | 21.50M |
| June 30, 2022 | -17.84M |
| March 31, 2022 | -9.143M |
| December 31, 2021 | 1.133M |
| September 30, 2021 | -1.444M |
| June 30, 2021 | -0.2337M |
| March 31, 2021 | 1.329M |
| December 31, 2020 | -0.0004M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 78.16M |
| Semnur Pharmaceuticals, Inc. | -4.347M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 7.642M |
| Total Expenses (Quarterly) | 122.37M |
| EPS Diluted (Quarterly) | -16.65 |
| Enterprise Value | 141.89M |
| Gross Profit Margin (Quarterly) | 14.73% |
| Profit Margin (Quarterly) | -1.52K% |
| Earnings Yield | -906.3% |
| Normalized Earnings Yield | -607.45 |